Product information: Please consult the summary of product characteristics for full product information. Flixonase Allergy Relief 50 micrograms per dose Nasal Spray (fluticasone propionate). Indications: Prevention and treatment of allergic rhinitis. Dosage: Adults 18 years and over: Two sprays into each nostril once a day if required. Maintenance: one spray per nostril once a day once control achieved. In some cases, twice daily dosing may be required for short periods. Use lowest possible maintenance dose. Max 4 sprays a day in each nostril. Do not use in those under 18 years of age. Contraindications: Hypersensitivity to ingredients. Precautions: If improvement in relief not seen within 7 days of continuous use, stop treatment and seek medical advice. Seek medical advice: if adequate relief not achieved after 7 days or require more than 6 months continuous use. Seek medical advice before use with: concomitant corticosteroid use, fever, nasal/sinus infection, recent nasal injury/surgery, nasal ulceration. Caution commencing in those withdrawing from systemic steroids, particularly if impairment of adrenal function suspected. Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. Reduced growth velocity has been observed in children treated with intranasal corticosteroids. Visual disturbances may occur with use of topical and systemic steroids. Contains benzalkonium chloride. Long-term use may cause oedema of the nasal mucosa. Side effects: Very common: Epistaxis. Common: Headache, unpleasant taste and smell, dryness and irritation of the nose and throat. See SPC for full details. Legal category: Pharmacy Only. Product Authorisation Holder: PA0678/095/001. Product Authorisation holder: Haleon Ireland Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland. Date of last revision: March 2023. Further information available on request.
Contains fluticasone propionate. Always read the label/leaflet.
